Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1297439
                    [Title] => Novartis, DOH vow to hasten progress in leprosy control
                    [Summary] => 
The Department of Health (DOH) and research-based Swiss healthcare company Novartis have vowed to continue their partnership in order to speed up the country’s progress in leprosy control.

                    [DatePublished] => 2014-03-06 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 655545
                    [Title] => BSP sees GIR hitting record $70 billion and BOP surplus of $8 billion
                    [Summary] => 
The Bangko Sentral ng Pilipinas (BSP) sees the country’s gross international reserves (GIR) hitting a new record level of $70 billion and the balance of payments (BOP) posting a surplus of $8 billion this year.
                    [DatePublished] => 2011-02-10 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1097197
                    [AuthorName] => Lawrence Agcaoili
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

ACCELERATING PROGRESS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1297439
                    [Title] => Novartis, DOH vow to hasten progress in leprosy control
                    [Summary] => 
The Department of Health (DOH) and research-based Swiss healthcare company Novartis have vowed to continue their partnership in order to speed up the country’s progress in leprosy control.

                    [DatePublished] => 2014-03-06 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 655545
                    [Title] => BSP sees GIR hitting record $70 billion and BOP surplus of $8 billion
                    [Summary] => 
The Bangko Sentral ng Pilipinas (BSP) sees the country’s gross international reserves (GIR) hitting a new record level of $70 billion and the balance of payments (BOP) posting a surplus of $8 billion this year.
                    [DatePublished] => 2011-02-10 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1097197
                    [AuthorName] => Lawrence Agcaoili
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

abtest

Novartis, DOH vow to hasten progress in leprosy control

March 6, 2014 - 12:00am

The Department of Health (DOH) and research-based Swiss healthcare company Novartis have vowed to continue their partnership in order to speed up the country’s progress in leprosy control.

Science and Environment

BSP sees GIR hitting record $70 billion and BOP surplus of $8 billion

By Lawrence Agcaoili | February 10, 2011 - 12:00am

The Bangko Sentral ng Pilipinas (BSP) sees the country’s gross international reserves (GIR) hitting a new record level of $70 billion and the balance of payments (BOP) posting a surplus of $8 billion this...

Business